The first rapid antigen influenza test to achieve 510(k) clearance as a Class II assay under the new FDA Reclassification performance requirements. Alere™ Reader provides objective result interpretation.
Used with either nasopharyngeal swab or nasal swab samples.
Results available in just 15 minutes.
Simple, straightforward testing procedure.
Provides accurate results and includes internal controls.
Suitable for a wide variety of healthcare settings.